Garuda - Garba Rujukan Digital

Bhisma Murti

Masters Program in Public Health, Universitas Sebelas Maret Surakarta

Author-ID : 10761162

Public Health

Published : 3 Documents Claim Missing Document

Claim Missing Document

Articles

Meta-Analysis: Effects of Night Shift Work on Hypertension and Sleep Patterns in Factory Workers Amanda Kesli Ramadhani; Hanung Prasetya; Bhisma Murti
Journal of Epidemiology and Public Health Vol. 7 No. 3 (2022)
Publisher : Masters Program in Public Health

Background: Night shift work has an impact on the health of factory workers. One of the impacts of night shift work is the risk of hypertension and disturbed sleep patterns. The purpose of this study was to determine how big the effect of night shift work on hypertension and sleep patterns in factory workers.Subjects and Method: This was a meta-analysis and systematic study with the population: factory workers. Intervention: night shift work. Comparation: morning and afternoon shift work. Outcome: hypertension and sleep patterns. The article search process was carried out according to the PRISM Flow Diagram and searched through several indexes such as PubMed, ScienceDirect, Google Schoolar, and Springer Link with the search keywords “Night Shift” AND “Hypertension” AND “Sleep” AND “Worker”. The articles used are articles from 2013-2022 and are written in English.Results: A total of 11 articles originating from the Asian continent (China, Indonesia, South Korea, Malaysia, and Japan) were considered suitable for meta-analysis. From the results of data analysis that has been carried out, it is known that factory workers who work night shifts have a risk of experiencing hypertension (aOR= 3.43; 95% CI= 2.48 to 4.72; p<0.001), and disturbed sleep patterns (aOR= 3.63; 95% CI= 2.66 to 4.95; p<0.001) compared with morning and afternoon shift workers and the results were statistically significant.Conclusion: Night shifts can increase the risk of hypertension and sleep disturbances in factory workers. Keywords: Night shift, hypertension, sleep pattern, factory worker Correspondence:Amanda Kesli Ramadhani. Masters Program in Public Health, Universitas Sebelas Maret, Jl. Ir. Sutami No.36, Kentingan, Jebres, Surakarta 57126, Central Java. Email. amandakesly@yahoo.com. Mobile: 085692832776.

Mortality Risk in COVID-19 Patients with HIV-Comorbidity: Meta-Analysis Nindita Arum Veibiani; Bhisma Murti; Argyo Demartoto
Journal of Epidemiology and Public Health Vol. 7 No. 4 (2022)
Publisher : Masters Program in Public Health

Background: Coronavirus disease 2019 or known as COVID-19 is a disease caused by severe acute respiratory coronavirus 2 (SARS-CoV-2). Comorbidities that are risk factors for COVID-19 death include hypertension, diabetes, heart disease, COPD, HIV (Human Immunodeficiency Virus), kidney failure, and cancer. This study aims to estimate the magnitude of the risk of death in COVID-19 patients with comorbid HIV, with a meta-analysis of the primary studies conducted by the previous authors.Subjects and Method: This study is a systematic review and meta-analysis with the following PICO, population: COVID-19 patients. Intervention: HIV comorbidity. Comparison: without co-morbid HIV. Outcome: Mortality. The articles used in this study were obtained from four databases, namely PubMed, Google Scholar, Springerlink, and Science direct, using the search keys "HIV/AIDS" AND "Mortality" OR "death" AND "COVID-19 OR SARS-CoV-2. The included article is a full-text English language with a cohort study design from 2020 to 2021 and reports the adjusted Odds Ratio (aOR) in a multivariate analysis. Article selection is done by using PRISMA flow diagram. Articles were analyzed using the Review Manager 5.3 application.Results: A total of 9 cohort studies involving 3,397,186 COVID-19 patients from America, Europe, and Africa were selected for a systematic review and meta-analysis. The data collected showed that COVID-19 patients with HIV comorbidities had a mortality risk of 3.30 times compared to COVID-19 patients without HIV comorbidities (aOR = 3.30; 95% CI = 2.87 to 3.81; p<0.001).Conclusion: HIV increases mortality risk in COVID-19 patients. Keywords: HIV, COVID-19, SARS-CoV-2, mortality Correspondence:Nindita Arum Veibiani. Masters Program in Public Health, Universitas Sebelas Maret, Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: nindita.veibiani@gmail.com. Mobile: 085800216969.

Effect of Diabetes Mellitus Comorbidity on Mortality Risk in Tuberculosis Patients who Received Tuberculosis Treatment: A Meta-Analysis Hakim Anasulfalah; Didik Gunawan Tamtomo; Bhisma Murti
Journal of Epidemiology and Public Health Vol. 7 No. 4 (2022)
Publisher : Masters Program in Public Health

Background: Tuberculosis or TB is a disease caused by the Mycobacterium tuberculosis complex. There are several comorbidities that experience severity and death when infected with tuberculosis or TB, namely hypertension, diabetes mellitus, cardiovascular disease, chronic kidney disease, cerebrovascular disease, and other diseases. This study aims to estimate the magnitude of the risk of death in Tuberculosis patients undergoing treatment with comorbid Diabetes Mellitus, with a meta-analysis of primary studies conducted by previous authors.Subjects and Method: This was a systematic review and meta-analysis with the following PICO, population: Tuberculosis patients. Intervention: comorbidities of chronic diabetes mellitus. Comparison: without comorbid diabetes mellitus. Outcome: death. The articles used in this study were obtained from three databases, namely Google Scholar, Pubmed, and Science Direct. Keywords to search for articles “Tuberclosis” OR TBC AND “Diabetes Mellitus” OR DM AND Mortality OR Death The included full-text articles are in English with a cohort study design from 2007 to 2021 and report the adjusted Odds Ratio (aOR) in a multivariate analysis. Article selection is done by using PRISMA flow diagram. Articles were analyzed using the Review Manager 5.3 application.Results: A total of 12 cohort studies involving tuberculosis patients undergoing treatment from America, Europe, Africa and Asia were selected for a systematic review and meta-analysis. The data collected showed tuberculosis patients undergoing treatment with comorbid Diabetes Mellitus had a 1.68 times risk of death compared to COVID-19 patients without comorbid chronic kidney disease (aOR = 1.68; 95% CI = 1.42 to 1.99; p<0.001).Conclusion: Diabetes mellitus comorbidity increases the risk of death in tuberculosis patients undergoing treatment. Keywords: Diabetes Melitus, Tuberculosis, mortality Correspondence:Hakim Anasulfalah. Masters Program in Public Health, Universitas Sebelas Maret, Jl. Ir. Sutami 36A, Surakarta 57126, Jawa Tengah. Email: isnanr28@gmail.com. Mobile: 081327215685.

Title

Found 3 Documents
Search

Abstract

Abstract

Abstract

Title Search

Found 3 Documents Search

Abstract

Abstract

Abstract

Title

Found 3 Documents
Search